Ampa, a neurotechnology firm specializing in transcranial magnetic stimulation (TMS) for mental health, appointed Dr. Doug Nemecek, former Cigna behavioral health chief, as an advisor. Nemecek brings over 20 years of experience in clinical strategy and health plan operations, aiming to enhance Ampa's payer and reimbursement strategies. His role will focus on generating evidence to secure durable insurance coverage for TMS treatments, potentially expanding patient access. This move supports Ampa's goal to improve quality and outcomes in mental health care through advanced, scalable TMS technology.
A KAYAK survey of 2,000 Brazilian travelers revealed Cristiano Ronaldo as the most desired football companion for trips, chosen by 60% of respondents. Vinícius Júnior and Endrick followed with 19% and 9%, respectively. The Northeast region of Brazil,...
A KAYAK survey of 2,000 Brazilian travelers found Cristiano Ronaldo is the most desired football player to travel with, chosen by 60% of respondents. Vinícius Júnior and Endrick followed with 19% and 9% respectively. Most Brazilians (59%) would take ...
The 16th annual PODD (Partnership Opportunities in Drug Delivery) conference will take place on October 29-30, 2026, in Boston, gathering over 1,000 industry leaders to discuss advancements in drug delivery systems. The event features over 150 sessio...
Oryn Therapeutics is progressing its next-generation Orynotide™ macrocyclic peptide platform aimed at treating inflammatory and autoimmune diseases through immune reprogramming rather than suppression. The company appointed Guy Rosenthal as CEO and e...
Dimensional Fund Advisors Ltd. has disclosed a 1.41% ownership stake in Advanced Medical Solutions Group PLC, holding 3,110,204 ordinary shares as of June 22, 2026. This disclosure follows regulatory requirements under the Takeover Code, indicating D...
